A phase II, patient and investigator-blinded, randomized,placebo-controlled study to evaluate efficacy, safety and tolerability of BAF312 in patients with stroke due to intracerebral hemorrhage (ICH)

September 24, 2018
https://clinicaltrials.gov/ct2/show/NCT03338998
Stroke
Principal Investigator: Stephan A Mayer, MD
Stroke, intracerebral, hemorrhage
Accepting Participants
(313)916-8071